Translation-X
Pre-clinicalDevelops novel therapeutics targeting RNA translation for genetic diseases.
Founded
2021
Focus
RNA & Gene Therapy
About
Develops novel therapeutics targeting RNA translation for genetic diseases.
Funding History
2Total raised: $35.5M
Series A$30MNovartis Venture FundNov 15, 2023
Seed$5.5MUndisclosedJun 15, 2022
Company Info
TypePrivate
Founded2021
LocationBasel, Switzerland
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
3Brain
Pre-clinical · Zug
Baxiva
Pre-clinical · Zug
AC Bioscience
Pre-clinical · Lausanne
Abrinca Genomics
Pre-clinical · Zurich
AdipoGen
Pre-clinical · Liestal
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile